19-Jan-2007 - Agilent Technologies Inc.

Agilent Technologies and Groton Biosystems Sign Co-Marketing Agreement for Pharmaceutical Manufacturing Solutions

Agilent Technologies Inc. and Groton Biosystems LLC announced an agreement to co-market solutions for the Process Analytical Technology (PAT) Initiative for the pharmaceutical industry in the United States and Canada.

PAT is a system for designing, analyzing and controlling manufacturing by measuring critical quality and performance attributes of raw and in-process materials and processes, all with the goal of ensuring final product quality.

The alliance is designed to benefit biopharmaceutical customers who perform in-process and final product testing in a wide range of production segments and who are looking for state-of-the-art online sampling with HPLC analysis for rapid quality-related decision-making.

The agreement, expected to expand to Europe and Asia in the near future, brings together Agilent's HPLC systems with Groton Biosystems' online sampling products and services.

Facts, background information, dossiers
  • Groton Biosystems
  • Agilent Technologies
  • services
More about Agilent
More about Groton Biosystems